These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 387330)

  • 1. Hemodynamic effects of oxprenolol and propranolol in hypertension.
    Franciosa JA; Johnson SM; Tobian LJ
    Clin Pharmacol Ther; 1979 Dec; 26(6):676-81. PubMed ID: 387330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Clin Pharmacol Ther; 1980 Jun; 27(6):733-43. PubMed ID: 6991196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of oxprenolol and propranolol.
    Materson BJ; Michael UF; Oster JR; Perez-Stable EC
    Clin Pharmacol Ther; 1976 Aug; 20(2):142-51. PubMed ID: 780037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference by sulphinpyrazone with the antihypertensive effects of oxprenolol.
    Ferrara LA; Mancini M; Marotta T; Pasanisi F; Fasano ML
    Eur J Clin Pharmacol; 1986; 29(6):717-9. PubMed ID: 3519237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States experience with oxprenolol in hypertension.
    Friedman B; Gray JM; Gross S; Levit SA
    Am J Cardiol; 1983 Nov; 52(9):43D-48D. PubMed ID: 6356865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
    Schlesinger Z; Ravid M; Meshulam R
    Cardiology; 1983; 70(4):199-205. PubMed ID: 6357438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the antihypertensive effect of propranolol and oxprenolol in man].
    Gilfrich HJ; Nicolescu RF; Rahn KH; Willems D
    Verh Dtsch Ges Inn Med; 1971; 77():934-7. PubMed ID: 5156090
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
    Andersson O; Berglund G; Bergman H; Cramer K; Fagerberg SE; Forsberg SA; Johnsen V; Lundkvist L; Rutle O; Sjolyst R
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):43-50. PubMed ID: 812664
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
    Becker AL
    S Afr Med J; 1976 Apr; 50(16):627-9. PubMed ID: 772831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
    Petrie JC; Jeffers TA; Robb OJ; Scott AK; Webster J
    Br Med J; 1980 Jun; 280(6231):1573-4. PubMed ID: 7000243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
    Gavras I; Gavras H; Sullivan PC; Tifft CP; Chobanian AV; Brunner HR
    J Clin Pharmacol; 1979 Jan; 19(1):8-14. PubMed ID: 368088
    [No Abstract]   [Full Text] [Related]  

  • 16. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxprenolol vs propranolol: a randomized, double-blind, multiclinic trial in hypertensive patients taking hydrochlorothiazide. Veterans Administration Cooperative Study Group.
    Hypertension; 1981; 3(2):250-6. PubMed ID: 7011964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.